⌘K

Home/Filings/4/0001213900-21-008162

4//SEC Filing

Goodman Tony 4

Accession 0001213900-21-008162

CIK 0001513525other

View on SEC.gov Company Profile

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 5:51 PM ET

Size

5.4 KB

Accession

0001213900-21-008162

Insider Transaction Report

Form 4

Period: 2021-02-08

ADIAL PHARMACEUTICALS, INC.ADIL

DirectorChief Operating Officer

Transactions

Award
Stock Option
2021-02-08+40,000→ 40,000 total
Exercise: $3.11From: 2021-03-08Exp: 2031-02-07→ Common Stock (40,000 underlying)

Footnotes (1)

[F1]The option vests pro rata on a monthly basis over 36 months.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ADIAL PHARMACEUTICALS, INC.

CIK 0001513525

Entity typeother

Related Parties

1

filerCIK 0001717971

Filing Metadata

Form type: 4
Filed: Feb 9, 7:00 PM ET
Accepted: Feb 10, 5:51 PM ET
Size: 5.4 KB

View on SEC.gov